GTS Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
3,163
+26
| +0.8% | +$1.8K | 0.01% | 1078 |
|
|
2025
Q1 | $218K | Buy |
+3,137
| New | +$218K | 0.01% | 1121 |
|
|
2024
Q4 | – | Sell |
-8,929
| Closed | -$1.06M | – | 1872 |
|
|
2024
Q3 | $1.06M | Sell |
8,929
-1,908
| -18% | -$227K | ﹤0.01% | 646 |
|
|
2024
Q2 | $1.55M | Sell |
10,837
-17,162
| -61% | -$2.45M | ﹤0.01% | 483 |
|
|
2024
Q1 | $3.6M | Buy |
27,999
+12,992
| +87% | +$1.67M | 0.01% | 217 |
|
|
2023
Q4 | $1.55M | Buy |
15,007
+2,350
| +19% | +$243K | ﹤0.01% | 462 |
|
|
2023
Q3 | $1.15M | Sell |
12,657
-21,517
| -63% | -$1.96M | ﹤0.01% | 471 |
|
|
2023
Q2 | $2.77M | Buy |
+34,174
| New | +$2.77M | 0.09% | 212 |
|